Heterocyclic Chemistry for Cancer and CNS Diseases

Dear Colleagues,

Heterocycles are prevalent in nature and they have the ability to engage in a wide variety of intermolecular interactions and in biochemical processes; consequently, they plays an important role in anti-cancer drug design (65% of the anti-cancer drugs that have received approval from the Food and Drug Administration (FDA) between 2010 and 2015 contain nitrogen-based heterocycles). New heterocyclic compounds have also been developed in the last ten years for the central nervous system (CNS), particularly for the treatment of Alzheimer's disease (AD). Molecular design for the development of cholinesterase (ChEIs) inhibitors, monoaminoxydases (MAOs) inhibitors, NMDA receptor antagonism, etc., involved the exploration of many natural products (their modified derivatives) and also synthetic heterocyclic compounds.

The purpose of the present Special Issue is to present the latest advances in the field of heterocyclic chemistry, used for possible pharmacological applications in cancer and CNS diseases (dementia, epilepsy, headache disorders, Parkinson's disease (PD), stroke and AD).

Prof. Jean-Pierre Bazureau
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.